Bayer MaterialScience’s Materials Help Bring Life-Saving Medical Devices to Market

Anaheim, CA, February 13, 2013 --(PR.com)-- Medical technology continues to advance by leaps and bounds. But bringing life-saving products to market requires more than medical breakthroughs: it also requires materials that can meet the rigorous challenges these applications demand. Bayer MaterialScience LLC offers grades of polycarbonate resins and blends formulated specifically to meet the unique requirements of the medical industry.

Bayer will highlight its portfolio of plastics and the applications these materials help bring to life at MD&M West – the world's largest medical device design and manufacturing event. Here’s a preview.

Bayer will unveil a new, medical-grade polycarbonate during the event. Makrolon® Rx2440 plastic possesses optimal flow properties and achieves faster recovery time in color shift from sterilization to part usage. This material is well suited to a variety of applications, including IV access, respiratory, surgical and renal care.

Also on display will be EntreVu® EX, a clear arthroscopic access cannula body designed by Cannuflow to help with fluid management during arthroscopic surgery. Bayer’s Makrolon Rx1452 polycarbonate was Cannuflow’s material of choice due to its moldability and biocompatibility. Also important was clarity, which helps the surgeon more easily see surgical knots.

Another medical application utilizing Bayer’s Makrolon resin is Infusion Innovations Inc.’s (I3) Q-FLO™ valve connector. According to the manufacturer, the Q-FLO connector offers improved safety and convenience for healthcare workers administering cytotoxic drugs to patients. The application required a reliable material meeting U.S. Food and Drug Administration (FDA) requirements along with a proven safety and functional profile.

Cardiac Science Corporation also needed a safe and reliable material for its product. The company selected Bayblend® FR3010 polycarbonate/acrylonitrile butadiene styrene (PC/ABS) blend resin for its Powerheart® G5 automated external defibrillator (AED) device. Specific colors for the device were chosen from Bayer’s LEDA® compounded color technology palette.

Attendees of MD&M West are invited to stop by Bayer booth #2021 to see firsthand these and other applications, and to learn more about the company’s broad range of proven materials for the medical and health care industry.

Watch Bayer’s newest medical video “Design of Plastic Parts for Medical Applications” (http://www.youtube.com/watch?v=PppHTibWSyg) to find out more about Bayer’s winning combination of material solutions and expertise for products in the medical field.

About Bayer MaterialScience LLC:
Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with approximately 14,800 employees at 30 production sites around the world and 2011 sales of 10.8 billion euros. Bayer MaterialScience’s 2011 sales in North America were $2.9 billion. The company manufactures high-tech polymer materials and develops innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries. Sustainability is central to Bayer MaterialScience LLC’s business and is based around the key areas of innovation, product stewardship, excellence in corporate management, social responsibility and respect for the environment.

Contact:

John Skabardonis, Phone: 412-777-5200

Email: john.skabardonis@bayer.com

For more information about Bayer MaterialScience LLC's medical polycarbonates, call 1-800-662-2927, email medicalinfo@bayer.com or pcinfo@bayer.com or visit www.bmsnafta.com.

For more information about Bayer MaterialScience’s color technology, please visit www.bayerfantasia.com/colors/leda/index.html.

Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Editor’s Note: Follow news from Bayer MaterialScience on Twitter: www.twitter.com/Bayer4materials.